BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27908308)

  • 1. Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort.
    Omma A; Erer B; Karadag O; Yilmaz N; Alibaz-Oner F; Yildiz F; Kalfa M; Kimyon G; Kiraz S; Direskeneli H; Erken E; Aksu K; Onat AM; Gül A; Ocal L; Inanc M; Kamali S
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):77-82. PubMed ID: 27908308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired quality of life, disability and mental health in Takayasu's arteritis.
    Yilmaz N; Can M; Oner FA; Kalfa M; Emmungil H; Karadag O; Yildiz F; Kimyon G; Yilmazer B; Gerdan V; Bilge SY; Ilhan B; Cobankara V; Kasifoglu T; Cefle A; Kisacik B; Onat AM; Akar S; Onen F; Erken E; Kiraz S; Aksu K; Keser G; Mumcu G; Direskeneli H
    Rheumatology (Oxford); 2013 Oct; 52(10):1898-904. PubMed ID: 23873821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey.
    Karabacak M; Kaymaz-Tahra S; Şahin S; Yıldız M; Adroviç A; Barut K; Direskeneli H; Kasapçopur Ö; Alibaz-Öner F
    Semin Arthritis Rheum; 2021 Feb; 51(1):192-197. PubMed ID: 33383295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life of patients with Takayasu's arteritis.
    Abularrage CJ; Slidell MB; Sidawy AN; Kreishman P; Amdur RL; Arora S
    J Vasc Surg; 2008 Jan; 47(1):131-6; discussion 136-7. PubMed ID: 18178464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of damage in Takayasu's arteritis.
    Kaymaz-Tahra S; Alibaz-Oner F; Direskeneli H
    Semin Arthritis Rheum; 2020 Aug; 50(4):586-591. PubMed ID: 32470706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
    Sahin S; Hopurcuoglu D; Bektas S; Belhan E; Adrovic A; Barut K; Canpolat N; Caliskan S; Sever L; Kasapcopur O
    Int J Rheum Dis; 2019 Jan; 22(1):132-139. PubMed ID: 30397997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
    Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
    Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
    Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
    Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances.
    Dammacco F; Cirulli A; Simeone A; Leone P; Pulli R; Angiletta D; Rubini G; Di Palo A; Vacca A; Dammacco R
    Clin Exp Med; 2021 Feb; 21(1):49-62. PubMed ID: 33026580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood Takayasu arteritis: disease course and response to therapy.
    Aeschlimann FA; Eng SWM; Sheikh S; Laxer RM; Hebert D; Noone D; Twilt M; Pagnoux C; Benseler SM; Yeung RSM
    Arthritis Res Ther; 2017 Nov; 19(1):255. PubMed ID: 29166923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Takayasu's Arteritis from the Patients' Perspectives: Measuring the Pulse to the Patient-Reported Outcomes.
    Luna-Vargas L; Hinojosa CA; Contreras-Yáñez I; Anaya-Ayala JE; Hinojosa-Azaola A
    Ann Vasc Surg; 2021 May; 73():314-320. PubMed ID: 33253809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India.
    Goel R; Kumar TS; Danda D; Joseph G; Jeyaseelan V; Surin AK; Bacon P
    J Rheumatol; 2014 Jun; 41(6):1183-9. PubMed ID: 24786922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
    Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.
    Yoshida M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Sugimura K; Fujii H; Shimokawa H; Harigae H
    Int J Rheum Dis; 2016 Jan; 19(1):87-94. PubMed ID: 26443306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
    Gudbrandsson B; Molberg Ø; Palm Ø
    Arthritis Res Ther; 2017 May; 19(1):99. PubMed ID: 28521841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and Renal Morbidity in Takayasu Arteritis: A Population-Based Retrospective Cohort Study From the United Kingdom.
    Goel R; Chandan JS; Thayakaran R; Adderley NJ; Nirantharakumar K; Harper L
    Arthritis Rheumatol; 2021 Mar; 73(3):504-511. PubMed ID: 32969145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachial-Ankle Pulse Wave Velocity is Increased and Associated with Disease Activity in Patients with Takayasu Arteritis.
    Wang Z; Dang A; Lv N
    J Atheroscler Thromb; 2020 Feb; 27(2):172-182. PubMed ID: 31270281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
    Furuta S; Cousins C; Chaudhry A; Jayne D
    J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum BAFF and APRIL levels in Indian patients with Takayasu arteritis.
    Zanwar A; Jain A; Gupta L; Chaurasia S; Kumar S; Misra DP; Misra R
    Clin Rheumatol; 2018 Dec; 37(12):3439-3442. PubMed ID: 29998368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
    Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
    Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.